Page last updated: 2024-10-22

acetazolamide and Basal Ganglia Diseases

acetazolamide has been researched along with Basal Ganglia Diseases in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takagi, T1
Matsumoto, T1
Kasuga, Y1
Horie, M1
Morishita, H1
Yasui, Y1
Ishikawa, T1

Other Studies

1 other study available for acetazolamide and Basal Ganglia Diseases

ArticleYear
[Hematoma of the basal ganglia in the newborn: non-surgical treatment].
    No to hattatsu = Brain and development, 1985, Volume: 17, Issue:4

    Topics: Acetazolamide; Basal Ganglia Diseases; Cerebral Hemorrhage; Female; Furosemide; Hematoma; Humans; In

1985